The Impact of Frailty, Sarcopenia, and Malnutrition on Liver Transplant Outcomes
Nikki Duong, Brett Sadowski, Amol S. Rangnekar – 30 April 2021
Nikki Duong, Brett Sadowski, Amol S. Rangnekar – 30 April 2021
Jindan Sheng, Susumu Kohno, Nobuhiro Okada, Nobuyuki Okahashi, Kana Teranishi, Fumio Matsuda, Hiroshi Shimizu, Paing Linn, Naoko Nagatani, Minako Yamamura, Kenichi Harada, Shin‐ichi Horike, Hiroshi Inoue, Seiji Yano, Sharad Kumar, Shunsuke Kitajima, Itsuki Ajioka, Chiaki Takahashi – 29 April 2021
Lixian Chen, Nan Wu, Lindsey Kennedy, Heather Francis, Ludovica Ceci, Tianhao Zhou, Niharika Samala, Konstantina Kyritsi, Chaodong Wu, Amelia Sybenga, Burcin Ekser, Wasim Dar, Constance Atkins, Vik Meadows, Shannon Glaser, Gianfranco Alpini – 29 April 2021
29 April 2021
Tingyan Wang, David A. Smith, Cori Campbell, Steve Harris, Hizni Salih, Kinga A. Várnai, Kerrie Woods, Theresa Noble, Oliver Freeman, Zuzana Moysova, Thomas Marjot, Gwilym J. Webb, Jim Davies, Eleanor Barnes, Philippa C. Matthews – 29 April 2021 – The association of liver biochemistry with clinical outcomes of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection is currently unclear, and the utility of longitudinally measured liver biochemistry as prognostic markers for mortality is unknown.
Hua Yu, Jun He, Wei Liu, Shuya Feng, Li Gao, Yingying Xu, Yawei Zhang, Xuyang Hou, Yan Zhou, Leping Yang, Xiongjun Wang – 29 April 2021
Amreen M. Dinani, Kris V. Kowdley, Mazen Noureddin – 29 April 2021
Eeeln Buckarma, Rory Smoot – 29 April 2021
David H. Adams – 29 April 2021